Navigation Links
Indegene Introduces TrialPedia 2.0 with 'Advantage Insights', Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry

ISELIN, New Jersey, August 20, 2012 /PRNewswire/ --

Indegene Inc. (, a leading global pharmaceutical and healthcare solutions provider, today announced the launch of TrialPedia 2.0 with Advantage Insights for clinical trial analytics and decision support.


The number of drugs approved by the USFDA over the years has been declining, and is testament to the difficulties pharmaceutical companies continue to face to drive revenues. As companies grapple with shrinking pipelines, stricter safety and regulatory requirements, and spiraling costs to bring products to the marketplace, the need for clinical trial analytics is paramount.

TrialPedia 2.0, a proprietary platform offered by Indegene, helps Clinical Development and Operations, R&D, Competitive Intelligence (CI), BD & Licensing, as well as Strategic Marketing professionals effectively analyze clinical literature and trial data seamlessly, and benchmark competitive Clinical Development Programs (CDPs) across the industry. TrialPedia provides quick and comprehensive answers to strategic clinical development and marketing questions including market evolution, competitive label claims, licensing options, and future sales projections. It includes industry leading features such as therapy area specific query parameters, claim space prediction tools, trial feasibility, operations analysis, and identification of competitive differentiators. TrialPedia 2.0 combines over 300 man-years of effort in assimilating knowledge to build a comprehensive solution.

Clients can further enhance the value of TrialPedia via Advantage Insights - a service bureau that is designed to enhance the business value of clinical trial analytics and help clients comprehensively research, study, monitor, report, and derive insights from the global clinical trial landscape. In this model, Indegene leverages TrialPedia and its expertise to perform analysis and reporting on behalf of the client. Clients can also avail of custom research and analysis through bundled Analyst Hours Support.

Manish Gupta, CEO - Indegene said "With Advantage Insights, in addition to clients gaining access to TrialPedia 2.0, they can leverage our deep research and analytics expertise for all their reporting and analysis needs. We believe that this will enable clients to navigate the business environment more effectively and with greater responsiveness."

About Indegene

Indegene is a leading provider of R&D, commercial and marketing solutions to global pharmaceutical and healthcare organizations. We partner with clients to drive both productivity and revenues by delivering better patient outcomes, optimizing cost, enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep scientific knowledge, flexible delivery models, proprietary technology, and a client-centric approach to drive transformational initiatives. To learn more about Indegene, visit us at

For further information contact:

US and Europe
Ann Marie Craggan
Indegene Inc.
Phone: +1-732-750-2901

Sherin Varghese
Genesis Burson-Marsteller
Mobile: +91-99161-15584

SOURCE Indegene Lifesystems Pvt Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
2. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
3. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
4. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
5. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
6. IDEV Technologies Introduces SurePath™ Guidewires
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
9. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
10. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
11. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology:
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):